The Hemangioblastoma Market region landscape shows significant variation, heavily influenced by the presence of specialized neurosurgical and rare disease centers, as well as the adoption rate of advanced therapeutic technologies. North America, particularly the United States, commands a substantial market share, primarily driven by high healthcare expenditure, the presence of key...